Ann Marie Raffis
Women's Health · Bedford, OHNPI 1083630966
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 96.5% of the total across 159 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 22 manufacturers, the largest accounting for just 13.8% — the pattern of someone who eats at a lot of different presentations. Among women's health clinicians in OH with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 159 payments — averaging $20.47 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pfizer$449
- Astellas Pharma US Inc$375
- AbbVie$338
- Organon$274
- Myovant Sciences Inc.$251
- Sumitomo Pharma America, Inc.$225
- plus $1K from 16 others
What the payments were for
- Food & beverage$3,14397%
- Education$1123%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pfizer | 18 | $449 |
| Astellas Pharma US Inc | 14 | $375 |
| AbbVie | 18 | $338 |
| Organon | 14 | $274 |
| Myovant Sciences Inc. | 11 | $251 |
| Sumitomo Pharma America, Inc. | 10 | $225 |
| Bayer | 11 | $215 |
| Sage Therapeutics, LLC | 8 | $208 |
| Agile Therapeutics, Inc. | 10 | $204 |
| Therapeuticsmd, Inc. | 12 | $153 |
| Evofem Biosciences, Inc. | 11 | $142 |
| Mayne Pharma Commercial LLC | 2 | $55 |
| Merck | 3 | $54 |
| Aspira Women's Health Inc | 1 | $53 |
| Exeltis, USA Inc. | 3 | $45 |
| Mylan Pharmaceuticals Inc. | 3 | $42 |
| Exact Sciences | 2 | $42 |
| Millicent US Inc | 2 | $37 |
| Lupin Inc. | 2 | $30 |
| Scynexis, Inc. | 2 | $28 |
| Novo Nordisk | 1 | $19 |
| Coopersurgical, Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- MYFEMBREE$103
How this compares
$3,255 in reported general payments places this provider in the 95th percentile of 333 women's health providers in Ohio.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 15 | $1,275 |
| ApriDesogestrel-Ethinyl Estradiol | 16 | $194 |
Paid to pharmacies, not to this prescriber.
Other women's health in Bedford
- Courtney ArnFranklin$195K
- Carrie van ZantBrookville$21K
- Cindy FarinaCleveland$10K
- Kathryn Lowry-CollinsLebanon$9K
- Angalesia RuckerCleveland$9K
- Vivian RuszkiewiczColumbus$6K
- Lauren ZugaWarren$6K
- Lisa LeeseOregon$5K
- Carrie BottiggiMayfield Heights$5K
- Tammy LawsonZanesville$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.